Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check5 days agoChange Detected- Revision: v3.5.0 added. - Revision: v3.4.3 removed.SummaryDifference0.1%

- Check12 days agoChange Detected- Revision updated: v3.4.2 to v3.4.3. This is a minor backend/version update and does not affect the study information or functionality.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This is a minor version update and does not change the study details or user-facing functionality.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'; removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision history updated to reflect addition of v3.3.4 and removal of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.